MGCA9 is a genetically heterogeneous disorder characterized by early‐onset seizures, developmental delay, intellectual disability, hypotonia, spasticity, increased serum lactate, and 3‐methylglutaconic aciduria, in which the clinical features are consistent with clinical characteristics of our cohort. The gene discussed is TIMM50; the disease is Intellectual disability.